Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to $15.1 million.

  • Anaptysbio's Net Income towards Common Stockholders rose 14600.47% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year increase of 4891.28%. This contributed to the annual value of -$145.2 million for FY2024, which is 1123.83% up from last year.
  • Anaptysbio's Net Income towards Common Stockholders amounted to $15.1 million in Q3 2025, which was up 14600.47% from -$38.6 million recorded in Q2 2025.
  • Anaptysbio's Net Income towards Common Stockholders' 5-year high stood at $15.1 million during Q3 2025, with a 5-year trough of -$46.7 million in Q2 2024.
  • For the 5-year period, Anaptysbio's Net Income towards Common Stockholders averaged around -$28.0 million, with its median value being -$31.4 million (2022).
  • Per our database at Business Quant, Anaptysbio's Net Income towards Common Stockholders plummeted by 612191.14% in 2022 and then skyrocketed by 14600.47% in 2025.
  • Anaptysbio's Net Income towards Common Stockholders (Quarter) stood at -$31.1 million in 2021, then grew by 28.8% to -$22.1 million in 2022, then crashed by 90.71% to -$42.2 million in 2023, then surged by 48.39% to -$21.8 million in 2024, then soared by 169.38% to $15.1 million in 2025.
  • Its Net Income towards Common Stockholders was $15.1 million in Q3 2025, compared to -$38.6 million in Q2 2025 and -$39.3 million in Q1 2025.